Roopal Thakkar
Vermögen: 12 Mio $ am 31.05.2026
Vermögen: 12 Mio $ am 31.05.2026
Roopal Thakkar is currently Chief Scientific Officer, Executive VP-R&D at AbbVie, Inc. since 2024.
Formerly, Dr. Thakkar was Chief Medical Officer & Senior Vice President at Global Therapeutics, Inc. Education includes an undergraduate degree from the University of Michigan and a doctorate from Wayne State University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2026 | 55’374 ( 0% ) | 12 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ABBVIE INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
| Unternehmen | Position | Ende |
|---|---|---|
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Commercial Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wayne State University School of Medicine
Wayne State University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen